Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Infection and Immunity|August 24, 2006
Innate immune responses to lung-stage helminth infection induce alternatively activated alveolar macrophagesJoshua J Reece, Mark C Siracusa, Alan L ScottJournal of Leukocyte Biology|August 23, 2008
Dynamics of lung macrophage activation in response to helminth infectionMark C Siracusa, Joshua J Reece, Joseph F Urban, et al.Infection and Immunity|May 29, 2008
Hookworm-induced persistent changes to the immunological environment of the lungJoshua J Reece, Mark C Siracusa, Teresa L Southard, et al.The Journal of Infectious Diseases|February 28, 2002
Merozoite surface protein 3 and protection against malaria in Aotus nancymai monkeysHajime Hisaeda, Allan Saul, Joshua J Reece, et al.Vaccine|November 17, 2020
Efficacy of the AV7909 anthrax vaccine candidate in guinea pigs and nonhuman primates following two immunizations two weeks apartJeffry D Shearer, Lisa Henning, Daniel C Sanford, et al.International Journal of Toxicology|July 20, 2021
Evaluation of the AV7909 Anthrax Vaccine Toxicity in Sprague Dawley Rats Following Three Intramuscular AdministrationsVeena V Rao, C Steven Godin, Michael J Lacy, et al.Vaccine|February 8, 2020
Development of a guinea pig inhalational anthrax model for evaluation of post-exposure prophylaxis efficacy of anthrax vaccinesMark R Perry, Boris Ionin, Roy E Barnewall, et al.Vaccine|June 30, 2022
Use of protective antigen of Bacillus anthracis as a model recombinant antigen to evaluate toll-like receptors 2, 3, 4, 7 and 9 agonists in mice using established functional antibody assays, antigen-specific antibody assays and cellular assaysJon Inglefield, Jason Catania, Andrea Harris, et al.Vaccine|September 19, 2019
Comparative immunogenicity and efficacy of thermostable (lyophilized) and liquid formulation of anthrax vaccine candidate AV7909M Autumn Smiley, Daniel C Sanford, Cheryl A Triplett, et al.Pageof 1